Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Background: Intravenous immunoglobulin (IVIg) is efficient and one of very few treatment options for patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). However, finding the optimal dose of IVIg for individual CIDP patients remains challenging. The dose of IVIg needs to b...

Full description

Bibliographic Details
Main Authors: Ludger Feyen, Christina Schaub, Julian Zimmermann, Louisa Nitsch
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Neurology International
Subjects:
CIDP
IVIg
maintenance therapy
dosing
Online Access:https://www.mdpi.com/2035-8377/15/1/27

Similar Items

Similar Items